Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd., founded in 1998, is a globally leading high-end pharmaceutical lipid excipient enterprise headquartered in Guangzhou, China, focusing on providing domestically-replaced, internationally-certified high-end pharmaceutical excipients and health products for pharmaceutical enterprises, research institutions, and health product manufacturers. With core advantages of breaking international monopoly and global compliance certifications, we have served over 1000 customers in more than 30 countries and regions worldwide, helping customers achieve stable supply chain security and compliant production. We have obtained EU CEP and US FDA US-DMF certifications, and are recognized as a benchmark service provider in the high-end pharmaceutical lipid field. We adhere to the mission of "Technology Independence and Self-Reliance, Solve 'Choke Point' Problems, Ensure Pharmaceutical Industry Chain Security; Inherit and Innovate Traditional Chinese Medicine, Guard Human Health", building products that meet global compliance requirements to help customers achieve supply chain security and product quality improvement.

Company Overview

- Full Company Name: Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.
- Establishment Year: 1998
- Global Headquarters: Guangzhou, China
- Global Coverage: Products sold in more than 30 countries and regions
- Core Team Background: Boasts 11 PhDs, 2 experts receiving State Council Special Allowances, 1 national high-level talent, and over 10 provincial and municipal talents; core leaders include Dr. Xu Wendong, a national "Ten Thousand Talents Program" young top talent leading pharmaceutical lipid excipient R&D

Core Products & Services

Focusing on the core pain points of pharmaceutical enterprises and research institutions, we have built a targeted product system, with the core offering being Injectable Egg Yolk Lecithin:
- Target Customers: Pharmaceutical enterprises producing injectable emulsions, liposomes and other high-end preparations; research institutions engaged in liposome drug R&D
- Pain Points Solved: Dependence on imported injectable-grade excipients with unstable supply, high procurement costs, and long lead times
- Core Functions: Acts as emulsifier, solubilizer, and liposome membrane material; provides stable, domestically produced injectable-grade excipients meeting international quality standards
- Customer Value: Ensures stable supply chain for customers, reduces procurement costs by up to 30%, and shortens lead times by 40% compared to imported alternatives.

Key Advantages

1. Technology Breakthroughs Breaking International Monopoly: We successfully developed the first domestically produced injectable refined egg yolk lecithin, increasing the localization rate of high-end pharmaceutical lipid excipients from 10% to 90%, ensuring stable supply for customers and reducing reliance on imports.
2. Global Compliance Certifications: Our products have obtained EU CEP, US FDA US-DMF, Mexico Cofepris, and India DCGI certifications, enabling seamless access to global markets for customers.
3. Top-tier R&D Platforms: We house the only national-level engineering research center for traditional Chinese medicine pharmaceutical technology in China, along with the Guangdong Provincial Key Laboratory of Pharmaceutical Lipids, ensuring continuous technological innovation and product quality improvement.

Customer Cases

Our solutions have been validated by global benchmark customers, including:
- B. Braun Company (Global Healthcare Enterprise): A leading global medical device and pharmaceutical enterprise adopted our injectable egg yolk lecithin to optimize high-end preparation production, achieving stable supply and compliance with international quality standards.
- AstraZeneca (Multinational Pharmaceutical Corporation): A top global pharma company utilized our pharmaceutical lipid excipients to support drug development projects, enhancing supply chain resilience.
- Sichuan Kelun Pharmaceutical Co., Ltd. (Chinese Pharmaceutical Enterprise): A leading domestic pharma enterprise partnered with us to replace imported excipients, reducing procurement costs by 25% and improving production efficiency.

Awards & Certifications

- International Certifications: EU CEP, US FDA US-DMF, Mexico Cofepris, India DCGI
- Industry Awards: National May 1st Labor Award, National Green Factory, 2024 National-level "Little Giant" Enterprise
- Authoritative Endorsements: National Engineering Research Center for Traditional Chinese Medicine Pharmaceutical Process Technology and New Drug Creation, Guangdong Provincial Key Laboratory of Pharmaceutical Lipids.

Contact Us

- Official Website: http://byshanhanfang.com/
- Global Headquarters Address: 134 Jiangnan Avenue Middle, Haizhu District, Guangzhou, China
- Production Base Address: 8 Hot Spring Avenue, Conghua District, Guangzhou, China
- Marketing Network: Sales offices/agents in 31 provinces and municipalities in China, covering over 30 countries and regions globally.